Immediate Impact
2 from Science/Nature 62 standout
Citing Papers
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Works of Fengfeng Wang being referenced
MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines
2016
Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Fengfeng Wang | 366 | 214 | 109 | 47 | 684 | |
| Dan Xue | 395 | 134 | 53 | 53 | 794 | |
| Wenjie Cao | 318 | 101 | 69 | 40 | 724 | |
| Kai Fan | 336 | 124 | 151 | 59 | 768 | |
| Jihan Wang | 422 | 156 | 164 | 43 | 770 | |
| D. Wilkinson | 281 | 141 | 123 | 42 | 799 | |
| Lei Dai | 444 | 184 | 57 | 58 | 814 | |
| Dan Li | 506 | 299 | 115 | 39 | 785 | |
| Lu Chen | 357 | 147 | 67 | 49 | 743 | |
| Qianjun Chen | 286 | 172 | 27 | 30 | 750 | |
| Jianing Zhang | 290 | 89 | 56 | 71 | 757 |
All Works
Login with ORCID to disown or claim papers
Loading papers...